Salah Ghabri

Nov 28, 2023 | healthaffairs.org | John K. Lin |James Barnes |Jalpa A. Doshi |Salah Ghabri |Peter L. Kolominsky-Rabas |Brian O’Rourke

Under the Inflation Reduction Act (IRA) of 2022, the Centers for Medicare and Medicaid Services (CMS) will begin negotiating drug prices for a subset of drugs in Medicare. In doing so, CMS must determine how to price each drug according to its benefits.